Compound 61965
Formula Pending
Research Abstract
GLP-1 candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61965 is a glp-1 asset inside glp-1 innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in post-market surveillance with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061965 with updates logged 2108-10-29.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Nomenclature
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061965
- [2] Operations Pulse • GLP-1 innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61965